Search Results

search

Search Filters

Organization
Bionical Emas
Picture1 (1).png
Bionical Emas sells EMAS Pharma to Kester Capital following strategic review
December 09, 2024 02:00 ET | Bionical Emas
Bionical Emas, the Early Access Programs and Clinical Trial Supply business, is selling EMAS Pharma to Kester Capital and an incoming executive team.